international journal of rheumatic diseases

Clipboard, Search History, and several other advanced features are temporarily unavailable. The index is based on the set of the scientist's We streamline legal and regulatory research, analysis, and workflows to drive value to organizations, ensuring more transparent, just and safe societies. Continue with Recommended Cookies. All rights reserved. scientist or scholar. The https:// ensures that you are connecting to the Data Source: Scopus, Explore, visually communicate and make sense of data with our, Metrics based on Scopus data as of April 2023. Bridging cytokines produced by dendritic cells, which form a bridge between the innate and acquired immune/autoimmune systems would be targets for treatment by biologicals in SLE, Potential for precision medicine in rheumatic diseases and systemic autoimmune diseases. Topics. 2010;62:222233. government site. Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II. /Feature/WoltersKluwer/OneWeb/SearchHeader/Search, Industry-leading clinical decision support, The worlds most trusted medical research platform, Evidence-based drug referential solutions, Targeting infection prevention, pharmacy and sepsis management, Cloud-based tax preparation and compliance, workflow management and audit solution, Integrated tax, accounting and audit, and workflow software tools, Tax Preparation Software for Tax Preparers, Discover our solution for ESG climate risk and regulatory requirements, Software solutions for risk & compliance, engineering & operations, and EHSQ & sustainability, Integrated regulatory compliance and reporting solution suite, Market leader in UCC filing, searches, and management, eOriginal securely digitizes the lending process from the close to the secondary market, Registered agent & business license solutions, Online resource for international arbitration research, Legal spend and matter management, AI legal bill review, and analytics solutions, All-in-one legal management software for legal departments, International Journal of Rheumatic Diseases, /Feature/WoltersKluwer/OneWeb/SearchBox/Ovid Submit Button Label. Accessibility of scholarly journals that accounts for both the number of citations De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB; International Committee of Medical Journal Editors. Asian continental ancestry group; cost of illness; observational study; symptoms flare up; systemic lupus erythematosus. Gout and hyperuricemia have likewise been associated with the development of cardiovascular disease and metabolic syndrome. Media Ranking in United Kingdom. We guarantee your privacy. The .gov means its official. Objective To map existing organizational care pathways in clinical centers of expertise that care for pregnant women affected by rare and complex connective tissue diseases (rcCTDs). Pages: 1358-1362. EDITORIAL. Bethesda, MD 20894, Web Policies The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Bookshelf Unauthorized use of these marks is strictly prohibited. Author (s): Asia Pacific League of Associations for Rheumatology. Clin Immunol. -. 20th ed Columbus, OH: McGrawHill; 2018:25152526. Our findings highlight an abundance of YouTube videos with useful information on SLE, that are mostly reliable and of high quality. 2021 Apr 7;17(733):684-689. International Journal of Rheumatic Diseases is a journal covering the technologies/fields/categories related to Rheumatology (Q3). Front Immunol. There are also other factors such as H-Index, Self-Citation Ratio, SJR, SNIP, etc. HHS Vulnerability Disclosure, Help The league publishes its APLAR Journal of Rheumatology in the International Journal of Rheumatic Diseases, a peer-reviewed medical journal . 2008;358(9):929939. Hobart TAS, AUSTRALIA. Disclaimer. -. PMID: 20704613 DOI: 10.1111/j . Indexed in the following public directories. . SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from the productivity and citation impact of the publications of a Miyazaki C, Sruamsiri R, Mahlich J, Jung W. J Med Econ. Ravi N, Choday S, Shantha Kumar V, Kc A, Parisapogu A, Ojinna BT, Tran HH, Sherpa ML, Shrestha N, Mohammed L. Cureus. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study. These recommendations provide guidance for COVID-19 vaccination in PRD. Keywords: Epub 2013 Mar 11. To investigate the neuropathic pain (NP) component in ankylosing spondylitis (AS) and to assess the relations between NP and disease characteristics. Epub 2016 Sep 30. is an employee of Japan Medical Data Center. Thus, successful treatments with biologicals targeting "bridging cytokines" produced by dendritic cells, which form a bridge between the innate and acquired immune/autoimmune systems, is of particular interest. Treattotarget in systemic lupus erythematosus: recommendations from an international task force. Performance & security by Cloudflare. We formulated recommendations to meet the urgent need for a consensus for vaccination against SARS-CoV-2 in PRD. The consent submitted will only be used for data processing originating from this website. To evaluate the presence of sarcopenia in patients with rheumatoid arthritis (RA). Most recommendations in this consensus are conditional . This site needs JavaScript to work properly. The antibody targeting B cell-activating factor belonging to the tumor necrosis factor family (BAFF) belimumab was the first biological approved for SLE. Bertsias GK, Tektonidou M, Amoura Z, et al. The official journal of the Asia Pacific League of Associations for Rheumatology. Ann Rheum Dis. National Library of Medicine In the future, it is expected that drugs with better efficacy and safety profiles will be used to apply therapeutic strategies, such as precision medicine, in which different molecular target drugs are used for patients classified by their conditions, and to set a therapeutic goal of the discontinuation of glucocorticoids. -, Rahman A, Isenberg DA. Overview Abstract Worldwide, osteoarthritis (OA) is estimated to be the fourth leading cause of disability. The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. 8600 Rockville Pike PMC doi: 10.1002/art.23067. We and our partners use data for Personalised ads and content, ad and content measurement, audience insights and product development. We guarantee your privacy. 2020 Apr;79(3):232-240. doi: 10.1007/s00393-020-00767-6. Author Cs Lau. Systemic lupus erythematosus In: Jameson JR, et al. This retrospective, observational cohort study identified patients with SLE (diagnosed April 2010 to March 2012), from the Japan Medical Data Center claims database. Unable to load your collection due to an error, Unable to load your delegates due to an error. -, Tsokos GC. International Journal of Rheumatic Diseases eISSN: 1756-185X pISSN: 1756-1841 Scope & Metrics Journal Specification Published Literature Similar Journals FAQs Key Metrics CiteScore 4 SJR Q3 Rheumatology SNIP 1 Topics Covered Rheumatoid arthritis Disease activity Cancer Ankylosing spondylitis Gout Cohort study Osteoporosis Rheumatology We and our partners use cookies to Store and/or access information on a device. 2011;365(22):21102121. Influence of social support on healthrelated quality of life in patients with systemic lupus erythematosus. You can email the site owner to let them know you were blocked. Epub 2023 Jan 17. However, in order to effectively educate patients, pitfalls such as misleading content, falsely elevated video characteristics and non-professional sources need to be made known to patients. All types of documents are considered, including citable and non citable documents. 2022 Dec;36(4):101814. doi: 10.1016/j.berh.2022.101814. Volume 26, Issue 7 p. 1217-1219. Relationship between flare and healthrelated quality of life in patients with systemic lupus erythematosus. The objective of this study was to evaluate the reliability and quality of the most viewed English-language YouTube videos on systemic lupus erythematosus (SLE). Before Trusted clinical technology and evidence-based solutions that drive effective decision-making and outcomes across healthcare. Outpatient visits, hospitalizations and emergency room stays were experienced by 295 (100%), 116 (39.3%) and 31 (10.5%) patients, respectively, over the 3-year study period. Moreover, a phase IIb clinical trial of baricitinib, a low-molecular-weight compound targeting Janus kinase 1/2, in patients with SLE revealed that baricitinib was significantly more effective for relieving arthritis and skin manifestations than placebo, and the trial met the primary endpoint. eCollection 2023. This study evaluated the influence of sarcopenia, especially muscle quality, on outcomes of antineutrophil cytoplasmic . Your IP: Unable to load your collection due to an error, Unable to load your delegates due to an error, The development of biologicals for the treatment of systemic lupus erythematosus. , >SCI> International Journal of Rheumatic Diseases, Copyright 2015- iikx.com All Rights Reserved. The humanistic and economic burden of systemic lupus erythematosus : a systematic review. and transmitted securely. Pharmacoeconomics. SCImago Journal Rank (SJR indicator) is a measure of scientific influence government site. Ann Rheum Dis. Journal Clubs. Early View. The site is secure. Z Rheumatol. eCollection 2023. International Journal of Rheumatic Diseases. official website and that any information you provide is encrypted The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Systemic lupus erythematosus. Submit Manuscript Share Your Experiences with Community International Journal of Rheumatic Diseases 2018 The Authors. MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT. Evolution of the number of total citation per document and external citation per document (i.e. International Journal of Rheumatic DiseasesSCI "INT J RHEUM DIS" The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. Front Pharmacol. The .gov means its official. 2023 May 15;14:1155421. doi: 10.3389/fimmu.2023.1155421. 2020 Jul;23(7):786-799. doi: 10.1080/13696998.2020.1740236. Editorial: journal accomplishments in just one short year. 2010 Feb;33(1):1. doi: 10.1111/j.1365-2605.2009.01041.x. Please enable it to take advantage of the complete set of features! Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor. For topics on particular articles, maintain the dialogue through the usual channels with your editor. Pearls. Many patients turn to online platforms to obtain healthcare information, but the quality and accuracy of the information is largely unknown. 2022 Oct 10;9:123-132. doi: 10.33393/grhta.2022.2470. -, Merrill JT, Neuwelt CM, Wallace DJ, et al. Arthritis Care Res (Hoboken). All rights reserved. doi: 10.1371/journal.pone.0285889. Efficacy and safety of rituximab in moderatelytoseverely active systemic lupus erythematosus: the randomized, doubleblind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Bethesda, MD 20894, Web Policies OA is strongly associated with ageing and the Asian region is ageing rapidly. Disclaimer. Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers. 2004 Sep 16;351(12):1250-1. doi: 10.1056/NEJMe048225. Request permission to reuse content from this site. and transmitted securely. Offering comprehensive tools and expert guidance to companies to help meet regulatory requirements to support sustainability efforts and manage ESG risks efficiently. Manage Settings International Journal of Rheumatic Diseases grants a place for the dissemination of innovative research findings in the swiftly growing areas of Gastroenterology and Rheumatology. Wolters Kluwer is a global provider of professional information, software solutions, and services for clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year. 2023 Feb;32(2):301-309. doi: 10.1177/09612033221146093. Keywords: Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. Ovid helps researchers, librarians, clinicians, and other healthcare professionals find important medical information so that they can make critical decisions to improve patient care, enhance ongoing research, and fuel new discoveries. 45.85.217.88 most cited papers and the number of citations that they have received J Rheumatol. If you would like to change your settings or withdraw consent at any time, the link to do so is in our privacy policy accessible from our home page.. such citations come from. 2017;186:2125. 2018 Jul 21;392(10143):222-231. doi: 10.1016/S0140-6736(18)31363-1. Bethesda, MD 20894, Web Policies Clipboard, Search History, and several other advanced features are temporarily unavailable.
Clark Baseball Schedule 2023, Articles I